Table I.
Baseline characteristics of Georgian patients
| Characteristics | All patients (n=72) |
Genotype 1 (n=32) |
Genotype 2 (n=21) |
Genotype 3 (n=19) |
p value |
|---|---|---|---|---|---|
| Sex | |||||
| Male, n (%) | 61 (84.7%) | 25 (78.1%) | 19 (90.5%) | 17 (89.5%) | 0.49 |
| Female n (%) | 11 (15.3%) | 7 (21.9%) | 2 (9.5%) | 2 (10.5%) | |
| Possible route of HCV acquisition | |||||
| IDU | 50 (69.4%) | 23 (71.8%) | 15 (71.4%) | 12 (63.1%) | 0.68 |
| Sexual transmition | 8 (11.1%) | 4 (12.5%) | 2 (9.5%) | 2 (10.5%) | |
| Blood transfusion | 2 (2.7%) | 2 (6.3%) | 0 | 0 | |
| Unknown | 12 (16.6) | 3 (9.3%) | 4 (19.5%) | 5 (26.3%) | |
| Baseline HCV viral load | |||||
| >600 000 IU/ml, n (%) | 43 (59.7%) | 18 (56.3%) | 15 (71.4%) | 10 (52.6%) | 0.42 |
| <600 000 IU/ml, n (%) | 29 (40.3%) | 14 (43.7%) | 6 (28.6%) | 9 (47.4%) | |